München, 17.05.2004 - Disclosure announcement transmitted by euro adhoc.The issuer is responsible for the content of this announcement.
Curanum AG CURANUM trebles net income for the period in first quarterof 2004
This Prime Standard-listed operator of care andnursing facilities increased its aggregate group sales from EUR 41.2million to EUR 43.3 million in the first quarter of the currentfinancial year, marking a rise of 5.1%. At 90.9%, income from nursingcare services made the largest contribution to the sales revenues ofEUR 42.6 million (previous year EUR 40.4 million), with shelteredapartments contributing 5.3%, outpatient services 1.3% and othersales revenues, e.g. refunds or rentals to third parties 2.6%.
Earnings before interest, taxes, depreciation and amortization(EBITDA) increased by almost 32% to EUR 2.3 million (year EUR 1.8million). The first quarter, which is traditionally weak in thenursing care segment, showed an outstanding trend in the financialyear 2004, with earnings before interest and taxes (EBIT) movingahead from EUR 1.2 million in the previous year to EUR 1.7 million(+36.5%). The financial result was improved slightly to EUR-229,000(previous year EUR-241,000), while earnings before tax (EBT)increased by 46.8% to EUR 1.4 million (previous year EUR 983,000).
With taxes on income coming to EUR 714,000 (previous year EUR696,000), consolidated net income for the period amounted to EUR668,000, which is three times the figure achieved in the previousyear?s reporting period (EUR 223,000). With 29,700,000 outstandingshares, this corresponds to earnings per share of EUR 0.02 (previousyear EUR 0.008) for the first quarter of the current financial year.
The company?s expansion is being driven forward according toplanning, with candidates for acquisition being sounded out and,should they fulfill the criteria established by CURANUM, subjected toclose examination. The cost reduction measures are already bearingfruit, as these quarterly financial statements show, and furtherincome-generating potential will be exploited in the currentfinancial year in the form of fixed cost degression and synergies inthe field of secondary services. The current figures show thatCURANUM AG is progressing according to planning. In view of thecourse of the financial year 2004 to date, the Management Board isassuming that its projections and plans will be at least fulfilled.
Please send your inquiries to:
CURANUM AGInvestor RelationsMaximilianstr. 35c80539 MunichTel. (089) 242065-60Fax (089) firstname.lastname@example.org
Further inquiry note:Bernd RotheTel.: +49 (0)89 242065-60E-Mail: email@example.comTel: +49 (0)89 242065 60FAX: +49 (0) 89 242065 10Email: firstname.lastname@example.org
Ende der Mitteilung
WKN: 524070ISIN: DE0005240709Marktsegment: CDAX, Classic All Share, Prime All Share, PrimeStandard, regulated dealing Bayerische Börse, FrankfurterWertpapierbörse; free trade Berliner Wertpapierbörse, HamburgerWertpapierbörse, Bremer Wertpapierbörse (BWB), Börse Düsseldorf,Baden-Württembergische Wertpapierbörse